The Genome Project–write leaders propose the development of virus-resistant cells, according to Science.
The award expands an existing collaboration between the firms for automated organism design.
ExxonMobil and Synthetic Genomics are moving forward with their exploration of algae-based biofuels, the San Diego Union-Tribune reports.
In Science this week: genetic overlap between five psychiatric disorders, and more.
The company, which was founded in 2016, said it would use the funding to further develop its core gene synthesis platform.
DNA Script has acquired an exclusive license to a novel DNA building block for use in enzymatic DNA synthesis.
GenScript believes that CustomArray's oligonucleotide synthesis and microarray manufacturing technology will enable it to better serve its customers.
The Boston-based synthetic biology company will use the proceeds to grow Bioworks3, its new organism foundry, and to expand into new markets.
In Nature this week: genomic analysis of malaria-carrying mosquitos reveals genetic diversity, and more.
The new institute, co-located with the China National GeneBank, will focus on synthetic biology technologies and applications.
Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.
Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.
Slate's Jane Hu compares some at-home genetic tests to astrology.
In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.